ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
35 announcements with these filters
Promoter Sachin D. Patel proposes to acquire up to 0.50% stake in Gujarat Themis Biosyn. The Rs.20 Crore inter-se transfer increases his holding to 2.77%.
Gujarat Themis Biosyn initiated arbitration against Optimus Drugs claiming Rs. 90.24 Crore. The dispute involves breached 'Take-or-Pay' obligations and terminated supply agreements.
Gujarat Themis Biosyn amicably settled its commercial dispute with Optimus Drugs Private Limited. The arbitration disposal results in no material financial impact or penalties.
Shareholders approved a special resolution to raise funds via a Qualified Institutions Placement. The approval enables the company to issue new equity shares.
Gujarat Themis Biosyn announced shareholders approved fund raising via Qualified Institutions Placement. The special resolution passed with 99.97% majority through a postal ballot process.